Eribulin sensitizes oral squamous cell carcinoma cells to cetuximab via induction of mesenchymal-to-epithelial transition

Hiroko Kitahara(Kanazawa University), Shuichi Kawashiri(Kanazawa University)
Oncology Reports
October 21, 2016
Cited by 25


Related Papers